Who Owns DRUG?

Bright Minds Biosciences Inc. — Institutional Ownership & 13F Holdings

$89.81

+0.65 (+0.73%)

Market Cap

$692.0M

Shares Outstanding

7,761,515

Institutional Holders

34

Total Inst. Value

$133.3M

% of Float Held

107.7%

QoQ Holder Change

+26

Institutional data as of Q1 2025

New Positions

10

Closed Positions

6

Increased

10

Decreased

8

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Cormorant Asset Management, LP$38.2M1,059,331
2Sio Capital Management, LLC$18.3M507,562
3Commodore Capital LP$18.0M500,000
4PERCEPTIVE ADVISORS LLC$16.0M444,649
5Vivo Capital, LLC$9.1M251,572
6ADAGE CAPITAL PARTNERS GP, L.L.C.$7.2M200,000
7MORGAN STANLEY$5.6M156,550
8Point72 Asset Management, L.P.$4.9M135,020
9Walleye Capital LLC$3.1M85,022
10Schonfeld Strategic Advisors LLC$2.7M75,601

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold DRUG?

As of Q1 2025, 34 institutional investors report holding DRUG (Bright Minds Biosciences Inc.) in their 13F filings.

What percentage of Bright Minds Biosciences Inc. is owned by institutions?

Institutional investors hold approximately 107.7% of Bright Minds Biosciences Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most DRUG?

The largest institutional holder of DRUG is Cormorant Asset Management, LP with $38.2M in shares.

Are institutions buying or selling DRUG?

This quarter, 10 institutions opened new positions in DRUG and 6 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.